
Sign up to save your podcasts
Or


This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.
By American College of Rheumatology5
1717 ratings
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.

504 Listeners

298 Listeners

128 Listeners

2,455 Listeners

3,374 Listeners

1,150 Listeners

122 Listeners

8,043 Listeners

120 Listeners

367 Listeners

68 Listeners

5 Listeners

375 Listeners

183 Listeners

6 Listeners